AI-generated summary
The authors report a case series of 20 patients with inferior alveolar nerve injury after extraction of impacted lower third molars, split into a photobiomodulation group (808-nm laser) and a mecobalamine control group. They found that the visual analog pain score improved more after photobiomodulation than after mecobalamine, and they describe the approach as appearing effective. The authors note the small sample and call for larger, placebo-controlled trials.
- Participants
- 20
- Who or what was studied
- Patients with inferior alveolar nerve injury following extraction of impacted lower third molars
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The authors state the sample size is limited and that larger, placebo-controlled, multi-center randomized trials are needed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 3 J/cm2
- Power
- 16 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Laser, Placebo-controlled, Control group, Inflammation, Sample size. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.